In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
about
Harnessing the apoptotic programs in cancer stem-like cellsMesenchymal stem cells as vectors for lung cancer therapyGenetically modified mesenchymal stromal cells in cancer therapyRole of nanotechnology and gene delivery systems in TRAIL-based therapiesPractical Issues with the Use of Stem Cells for Cancer Gene TherapyEvidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro.Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.Cytotherapies in multiple myeloma: a complementary approach to current treatments?TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progressionA simple method to generate adipose stem cell-derived neurons for screening purposes.pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.Evaluation of age effects on doxorubicin-induced toxicity in mesenchymal stem cells.Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Q26801037-C36390AA-9B19-470C-89A6-6C440C5B43EDQ26853498-E0DC9CE6-CF07-414A-ADA7-F075B2226A1CQ28071840-B8016567-3C1D-4A4A-85FE-695CA054D09BQ28076798-794BB065-DB30-4603-BD71-76DEB7F80138Q28085238-5AC8219B-3A7E-4435-84EB-81B522588F5AQ34652128-B769F2BB-B6E9-4B3D-82DC-156AC6EFC48CQ35159519-DE46D81D-7114-42ED-9114-F3F63C77CC17Q37372102-2DD64C50-AA73-4B09-8595-CC9E1D9C1E33Q38108819-52F24506-2A6B-40DA-AFC3-162D9493601FQ38750240-34FE3974-253B-4448-8B5C-99768E9AE55FQ38927008-186F7DDF-7372-4271-A34D-63090D2ACF89Q38938230-E37BA67A-D9B8-4C52-A427-1AA048DE08A7Q38940894-6C80BFC4-C236-4AEC-8628-D5FA3FE0EC40Q39030703-8F00202E-13FB-4DFA-BBB6-2BAC5636F6D5Q39455822-194F5C49-9B2C-4B05-AE3E-0D0007C7949AQ42368100-CFD05949-170C-4ECC-9069-2CF37551E16BQ55329991-EE08654D-5097-4F7A-9762-091BD939FF24Q55471455-C243B95E-45E8-46D9-9BB8-C9545D4791B7Q57174410-341C4FB6-F464-4740-9FDA-3131FF0526B0
P2860
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@en
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@nl
type
label
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@en
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@nl
prefLabel
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@en
In vitro anti-myeloma activity ...... erived mesenchymal stem cells.
@nl
P2860
P50
P1476
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells
@en
P2093
Franco Dammacco
P2860
P304
P356
10.1111/J.1365-2141.2012.09082.X
P407
P577
2012-03-16T00:00:00Z